PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2128403
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2128403
The global oxygen therapy equipment market was valued at USD 3.41 billion in 2025 and is projected to grow from USD 3.53 billion in 2026 to USD 4.95 billion by 2034, registering a CAGR of 4.3% during 2026-2034. North America dominated the market with a 36.95% share in 2025, supported by advanced healthcare infrastructure, growing respiratory disease prevalence, and increasing adoption of homecare oxygen therapy solutions.
Market Overview
Oxygen therapy equipment includes devices designed to deliver supplemental oxygen to patients suffering from low blood oxygen levels or respiratory disorders. These products include oxygen concentrators, oxygen cylinders, liquid oxygen systems, masks, nasal cannulas, and other accessories. The growing burden of respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD), asthma, pneumonia, and sleep apnea is significantly driving demand worldwide.
The COVID-19 pandemic further emphasized the importance of oxygen support systems across hospitals, emergency care facilities, and homecare settings. Rising air pollution, smoking-related illnesses, and an expanding elderly population continue to contribute to market growth. According to the CDC, approximately 14.2 million people in the U.S. were living with COPD in 2021, highlighting the strong need for oxygen therapy solutions.
Market Size and Forecast
Key Market Trends
A major trend shaping the oxygen therapy equipment market is the increasing preference for portable and user-friendly oxygen delivery systems. Patients increasingly seek lightweight, battery-powered, and travel-friendly oxygen concentrators that support mobility and improve quality of life.
Manufacturers are focusing on quieter operations, compact designs, and enhanced battery performance to meet rising demand in homecare environments. The trend is especially visible among aging populations and patients requiring long-term oxygen therapy outside traditional healthcare settings.
Market Drivers
Rising Prevalence of Respiratory Diseases
The increasing incidence of COPD, asthma, chronic bronchitis, and other respiratory disorders remains the primary growth driver. Aging populations and worsening environmental pollution are contributing to higher respiratory complications globally, creating sustained demand for oxygen therapy equipment.
Growing Home Healthcare Adoption
Patients increasingly prefer home-based treatment over prolonged hospital stays. Oxygen therapy equipment is becoming a key component of homecare services due to convenience, cost-effectiveness, and advancements in device usability.
Market Restraints
Dependence on Reliable Power Infrastructure
Oxygen concentrators require continuous electricity to operate effectively. In regions with unstable power supplies, equipment reliability becomes a challenge. Backup oxygen cylinders add additional operational costs, limiting adoption in developing markets.
Market Opportunities
Expansion of Homecare Oxygen Solutions
The rapid expansion of home healthcare presents substantial opportunities for manufacturers. Companies are developing compact, quieter, and easy-to-operate devices specifically designed for home use. In June 2025, Inogen launched its next-generation Voxi oxygen concentrator aimed at the growing homecare segment.
Market Challenges
High Equipment Costs
Advanced portable oxygen concentrators remain expensive for many patients. Long-term therapy involves recurring costs including maintenance, accessories, and electricity consumption. Limited reimbursement coverage in several countries further impacts affordability and adoption.
By Product Type
Oxygen Concentrators dominated the market in 2025 due to their ability to provide continuous oxygen without refilling requirements. Technological advancements and increasing product launches continue to support segment growth.
The oxygen delivery devices segment is expected to grow at a CAGR of 4.4% during the forecast period.
By Portability
The stationary segment held the largest market share in 2025 due to widespread use in hospitals and homecare settings requiring continuous oxygen flow.
The portable segment is expected to grow at a CAGR of 5.0%, driven by rising patient preference for mobility and convenience.
By Application
The COPD segment dominated the market in 2025 owing to the high prevalence of the disease and long-term oxygen requirements among patients.
The pneumonia segment is projected to grow at a CAGR of 4.1% through 2034.
By End User
Homecare settings accounted for the largest market share in 2025 and are expected to hold 37.0% market share in 2026. The shift toward home-based healthcare and improved device accessibility continues to strengthen this segment.
Regional Analysis
North America
North America led the global market with a value of USD 1.26 billion in 2025. Strong healthcare infrastructure, technological innovation, and high respiratory disease prevalence support regional growth.
Europe
Europe is projected to reach USD 0.99 billion by 2026 and register a growth rate of 6.3%, making it one of the fastest-growing regions.
Asia Pacific
Asia Pacific is expected to reach USD 0.87 billion in 2026 and emerge as the fastest-growing regional market due to expanding healthcare infrastructure and rising respiratory disease burden.
Latin America and Middle East & Africa
Latin America is projected to reach USD 0.22 billion in 2026, while the GCC market is expected to reach USD 0.05 billion. Rising awareness of respiratory care and improving healthcare access continue to support growth in these regions.
Competitive Landscape
The oxygen therapy equipment market is moderately concentrated, with leading companies focusing on product innovation, strategic partnerships, and global expansion.
Major players include:
Recent developments include Inogen's strategic partnership with Yuwell Medical in January 2025 and VARON's launch of advanced portable oxygen concentrators across Europe in April 2026.
Conclusion
The oxygen therapy equipment market is poised for steady growth, expanding from USD 3.41 billion in 2025 to USD 4.95 billion by 2034. Rising respiratory disease prevalence, increasing adoption of home healthcare, and growing demand for portable oxygen concentrators are expected to drive market expansion. While affordability and infrastructure limitations remain challenges, ongoing technological advancements and product innovations are creating significant opportunities for manufacturers worldwide. North America currently leads the market, while Asia Pacific is expected to witness the fastest growth through 2034, supported by improving healthcare access and a growing patient population.
Segmentation By Product Type, Portability, Application, End-User, and Region
By Product Type * Oxygen Concentrators
By Portability * Stationary
By Application * COPD
By End-User * Hospitals & ASCs
By Region * North America (By Product Type, Portability, Application, End-User, and Country)